0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Pulmonary Edema Associated With Intravenous Vinblastine

Robert H. Israel, MD; John P. Olson, MD
JAMA. 1978;240(15):1585. doi:10.1001/jama.1978.03290150031007.
Text Size: A A A
Published online

To the Editor.—  A recent case demonstrated an association between the intravenous (IV) administration of vinblastine and the development of pulmonary edema.

Report of a Case.—  A 64-year-old woman is receiving chemotherapy for infiltrating duct carcinoma of the breast metastatic to bones. A breast mass was diagnosed in May 1972, with a subsequent right radical mastectomy. One of 24 axillary nodes was abnormal. Bony metastasis appeared in November 1974. She has been treated sequentially with estrogen, cryohypophysectomy, and combination chemotherapy (first with cyclophosphamide [Cytoxan], methotrexate, and fluorouracil; then doxorubicin hydrochloride [Adriamycin] and cyclophosphamide and recently with mitomycin and vinblastine sulfate). She has hypertension, which has been therapeutically controlled since 1969. The insidious onset of congestive heart failure developed in May 1977, consistent with doxorubicin toxicity (total dose, 400 mg/sq m). Doxorubicin therapy was discontinued, and she responded to digitalization and diuresis. She has remained well compensated with digoxin, hydrochlorothiazide (Hydrodiuril),

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

33 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();